Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:889-893
Published online before print January 26, 2006, doi: 10.1161/01.STR.0000204184.34946.41
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/3/889    most recent
01.STR.0000204184.34946.41v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qu, K.
Right arrow Articles by Wong, P. T.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qu, K.
Right arrow Articles by Wong, P. T.-H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYSTEINE
*HYDROGEN SULFIDE

(Stroke. 2006;37:889.)
© 2006 American Heart Association, Inc.


Original Contributions

Hydrogen Sulfide Is a Mediator of Cerebral Ischemic Damage

Kun Qu, BSc; Christopher P.L.H. Chen, BMBCh, FRCP; Barry Halliwell, DPhil, DSc; Philip K. Moore, PhD Peter T.-H. Wong, PhD

From the Departments of Pharmacology (K.Q., C.P.L.H.C., P.K.M., P.T.-H.W.) and Biochemistry (B.H.), Yong Loo Lin School of Medicine, National University of Singapore, Kent Ridge, Singapore; and Department of Neurology (C.P.L.H.C.), National Neuroscience Institute, Singapore General Hospital Campus, Singapore General Hospital.

Correspondence to Dr Peter T.-H. Wong, Department of Pharmacology, National University of Singapore, 18 Medical Dr, Singapore 117597. E-mail phcwth{at}nus.edu.sg

Background and Purpose— We observed recently that elevated plasma cysteine levels are associated with poor clinical outcome in acute stroke patients. In a rat stroke model, cysteine administration increased the infarct volume apparently via its conversion to hydrogen sulfide (H2S). We therefore investigated the effects of H2S and the inhibition of its formation on stroke.

Methods— Cerebral ischemia was studied in a rat stroke model created by permanent occlusion of the middle cerebral artery (MCAO). The resultant infarct volume was measured 24 hours after occlusion.

Results— Administration of sodium hydrosulfide (NaHS, an H2S donor) significantly increased the infarct volume after MCAO. The NaHS-induced increase in infarct volume was abolished by the administration of dizolcilpine maleate (an N-methyl-D-aspartate receptor channel blocker). MCAO caused an increase in H2S level in the lesioned cortex as well as an increase in the H2S synthesizing activity. Administration of 4 different inhibitors of H2S synthesis reduced MCAO-induced infarct volume dose dependently. The potency of these inhibitors in effecting neuroprotection in vivo appeared to parallel their potency as inhibitors of H2S synthesis in vitro. It also appeared that most of the H2S synthesizing activity in the cortex results from the action of cystathionine ß-synthase.

Conclusions— The present results strongly suggest that H2S plays a part in cerebral ischemic damage after stroke. Inhibition of H2S synthesis should be investigated for its potential as a novel neuroprotective stroke therapy.


Key Words: hydrogen sulfide • N-methyl-D-aspartate • receptor • stroke




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
Z. Xu, G. Prathapasinghe, N. Wu, S.-Y. Hwang, Y. L. Siow, and K. O
Ischemia-reperfusion reduces cystathionine-{beta}-synthase-mediated hydrogen sulfide generation in the kidney
Am J Physiol Renal Physiol, July 1, 2009; 297(1): F27 - F35.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Chiku, D. Padovani, W. Zhu, S. Singh, V. Vitvitsky, and R. Banerjee
H2S Biogenesis by Human Cystathionine {gamma}-Lyase Leads to the Novel Sulfur Metabolites Lanthionine and Homolanthionine and Is Responsive to the Grade of Hyperhomocysteinemia
J. Biol. Chem., April 24, 2009; 284(17): 11601 - 11612.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L.-F. Hu, M. Lu, Z.-Y. Wu, P. T.-H. Wong, and J.-S. Bian
Hydrogen Sulfide Inhibits Rotenone-Induced Apoptosis via Preservation of Mitochondrial Function
Mol. Pharmacol., January 1, 2009; 75(1): 27 - 34.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. L. Wallace, M. Dicay, W. McKnight, and G. R. Martin
Hydrogen sulfide enhances ulcer healing in rats
FASEB J, December 1, 2007; 21(14): 4070 - 4076.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. C. Chuah, P. K. Moore, and Y. Z. Zhu
S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2693 - H2701.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Geng, Y. Cui, J. Zhao, F. Yu, Y. Zhu, G. Xu, Z. Zhang, C. Tang, and J. Du
Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1608 - R1618.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. P. Doyle, K. L. Suchland, T. M.P. Ciesielski, N. S. Lessov, D. K. Grandy, T. S. Scanlan, and M. P. Stenzel-Poore
Novel Thyroxine Derivatives, Thyronamine and 3-iodothyronamine, Induce Transient Hypothermia and Marked Neuroprotection Against Stroke Injury
Stroke, September 1, 2007; 38(9): 2569 - 2576.
[Abstract] [Full Text] [PDF]